Form 4: AstraZeneca Executive Acquires Shares

Mani Sharma, SVP of AstraZeneca, acquired ordinary shares under the company's Share Incentive Plan.

Summary

• Mani Sharma, SVP, Group Controller and Head of Global Finance Services at AstraZeneca PLC, acquired 2 ordinary shares on July 6, 2026.
• The acquisition was made under the Issuer's Share Incentive Plan.
• The purchase price was $190.43 per share, equivalent to GBP142.492.
• The conversion rate used was GBP1.0000 to $1.3364, as published by the Board of Governors of the Federal Reserve System on July 2, 2026.
• Following this transaction, Sharma beneficially owns 19,265.4659 ordinary shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine transaction by an executive and does not contain new financial performance data or strategic announcements.

Positives

• Executive demonstrates continued investment in the company through share acquisition.
• Acquisition made under a formal Share Incentive Plan, suggesting a structured approach to employee compensation and ownership.

Future Outlook

No specific forward-looking statements or guidance are present in this filing, as it solely reports a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for executives and directors, indicating changes in their beneficial ownership of company stock. This specific filing shows an executive acquiring shares, which can be interpreted as a positive signal of confidence in the company's prospects.

Stakeholder Impact

• Shareholders: The acquisition by an executive may be viewed positively, signaling confidence in the company's future performance. However, the small number of shares acquired (2) limits its significant impact.

Key Dates

Keywords

AstraZeneca, Form 4, Share Acquisition, Insider Trading, Share Incentive Plan, SEC Filing, Mani Sharma